Submitted:
22 May 2024
Posted:
23 May 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Baptista, R.S.; Pagliuca, L.M.F.; Sampaio, A.F.A.; de França, I.S.X. Sexuality: Experience of Women with Physical Disabilities. Open J. Nurs. 2014, 04, 920–927. [Google Scholar] [CrossRef]
- Streur, CS, Schafer, CL, Garcia, VP, Quint, EH, Sandberg, DE, Wittmann, DA. “If Everyone Else is Having This Talk with Their Doctor, Why Am I Not Having This Talk with Mine?”: The Experiences of Sexuality and Sexual Health Education of Young Women with Spina Bifida. J Sex Med. 2019, 16, 853–9. [Google Scholar] [CrossRef] [PubMed]
- Rugoho, T.; Maphosa, F. Challenges faced by women with disabilities in accessing sexual and reproductive health in Zimbabwe: The case of Chitungwiza town. Afr. J. Disabil. 2017, 6, 8. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Reproductive health indicators : guidelines for their generation, interpretation and analysis for global monitoring. 2006, 63.
- Sathyanarana Rao, T, Nagaraj, AK. Female sexuality. Indian J Psychiatry 2015, 57, 296.
- Wylie, K. Sexuality: it's not just sex. J R Soc Med. 2007, 100, 300–300. [Google Scholar] [CrossRef] [PubMed]
- Coverdale, JH, Balon, R, Roberts, LW. Teaching Sexual History-Taking: A Systematic Review of Educational Programs: Acad Med. 2011, 86, 1590–5.
- Mollaioli, D.; Ciocca, G.; Limoncin, E.; Di Sante, S.; Gravina, G.L.; Carosa, E.; Lenzi, A.; Jannini, E.A.F. Lifestyles and sexuality in men and women: the gender perspective in sexual medicine. Reprod. Biol. Endocrinol. 2020, 18, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Nosek, M.A.; Rintala, D.H.; Young, M.E.; Howland, C.A.; Foley, C.C.; Rossi, D.; Chanpong, G. Sexual functioning among women with physical disabilities. Arch. Phys. Med. Rehabilitation 1996, 77, 107–115. [Google Scholar] [CrossRef] [PubMed]
- Bloom, TL, Mosher, W, Alhusen, J, Lantos, H, Hughes, RB. Fertility Desires and Intentions Among U.S. Women by Disability Status: Findings from the 2011–2013 National Survey of Family Growth. Matern Child Health J 2017, 21, 1606–15.
- Nazari, F.; Shaygannejad, V.; Sichani, M.M.; Mansourian, M.; Hajhashemi, V. Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life. BMC Urol. 2020, 20, 1–10. [Google Scholar] [CrossRef]
- Guo, Z.-N.; He, S.-Y.; Zhang, H.-L.; Wu, J.; Yang, Y. Multiple sclerosis and sexual dysfunction. Asian J. Androl. 2012, 14, 530–535. [Google Scholar] [CrossRef] [PubMed]
- Mohammadi, K.; Rahnama, P.; Rafei, Z.; Ebrahimi-Aveh, S.M.; Montazeri, A. Factors associated with intimacy and sexuality among young women with multiple sclerosis. Reprod. Heal. 2020, 17, 1–6. [Google Scholar] [CrossRef] [PubMed]
- Zamani, M.; Tavoli, A.; Khasti, B.Y.; Sedighimornani, N.; Zafar, M. Sexual Therapy for Women with Multiple Sclerosis and Its Impact on Quality of Life. 2017, 12, 58–65.
- Bronner, G.; Elran, E.; Golomb, J.; Korczyn, A.D. Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention. Acta Neurol. Scand. 2010, 121, 289–301. [Google Scholar] [CrossRef] [PubMed]
- Najafidoulatabad, S.; Mohebbi, Z.; Nooryan, K. Yoga Effects on Physical Activity and Sexual Satisfaction among Iranian Women with Multiple Sclerosis: A Randomized Controlled Trial. Afr. J. Tradit. Complement. Altern. Med. 2014, 11, 78–82. [Google Scholar] [CrossRef]
- Salari, N.; Hasheminezhad, R.; Abdolmaleki, A.; Kiaei, A.; Razazian, N.; Shohaimi, S.; Mohammadi, M. The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis. Neurol. Sci. 2022, 44, 59–66. [Google Scholar] [CrossRef] [PubMed]
- Krupp, LB, LaRocca, NG, Muir-Nash, J, Steinberg, AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989, 46, 1121–3.
- Sanders, A.S.; Foley, F.W.; LaRocca, N.G.; Zemon, V. The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19). Sex. Disabil. 2000, 18, 3–26. [Google Scholar] [CrossRef]
- Rosen, C. Brown, J. Heiman, S. Leib R. The Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function. J Sex Marital Ther. 2000, 26, 191–208. [Google Scholar]
- Creswell, JW. Educational research: planning, conducting, and evaluating quantitative and qualitative research. 4th ed. Boston: Pearson; 2012. 650 p.
- Fereshtehnejad, S. M. , Ghaffari, M. , Aarabi, M. H., et al. Exploring the sexuality of women with multiple sclerosis. Multiple Sclerosis and Related Disorders 2020, 45, 102376. [Google Scholar]
- Bozman, A. W. , Alschuler, K. N., Fenton, B., & Ehde, D. M. Sexual dysfunction in multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders 2016, 10, 103–18. [Google Scholar]
- Bostwick, J. M. , & Kaskutas, L. A. Sexual dysfunction in multiple sclerosis. Archives of Neurology 1997, 54, 1474–8. [Google Scholar]
- Yılmaz, S.D.; Gumus, H.; Odabas, F.O.; Akkurt, H.E.; Yılmaz, H. Sexual Life of Women with Multiple Sclerosis: A Qualitative Study. Int. J. Sex. Heal. 2016, 29, 147–154. [Google Scholar] [CrossRef]
- Bartnik, P.; Wielgoś, A.; Kacperczyk, J.; Pisarz, K.; Szymusik, I.; Podlecka-Piętowska, A.; Zakrzewska-Pniewska, B.; Wielgoś, M. Sexual dysfunction in female patients with relapsing-remitting multiple sclerosis. Brain Behav. 2017, 7, e00699–e00699. [Google Scholar] [CrossRef] [PubMed]
- Marck, C.H.; Jelinek, P.L.; Weiland, T.J.; Hocking, J.S.; De Livera, A.M.; Taylor, K.L.; Neate, S.L.; Pereira, N.G.; Jelinek, G.A. Sexual function in multiple sclerosis and associations with demographic, disease and lifestyle characteristics: an international cross-sectional study. BMC Neurol. 2016, 16, 1–9. [Google Scholar] [CrossRef]
- Lew-Starowicz, M.; Rola, R. Therapy of female sexual dysfunction in multiple sclerosis. Menopausal Rev. 2013, 2, 166–174. [Google Scholar] [CrossRef]
| N (%) | ||
| Age | ||
| 18-24 | 6 (4.6) | |
| 25-34 | 31 (23.8) | |
| 35-50 | 73 (56.2) | |
| 50+ | 20 (15.4) | |
| Educational level | ||
| High school at most | 45 (34.6) | |
| University | 32 (24.6) | |
| MSc/ PhD | 53 (40.8) | |
| Married/ Living together with partner | 99 (76.2) | |
| Children | 83 (63.8) | |
| Number of children | ||
| 1 | 36 (43.4) | |
| 2 | 40 (48.2) | |
| 3 | 6 (7.2) | |
| 4 | 1 (1.2) | |
| Menopause | 33 (25.4) | |
| Time from symptoms onset (years), mean (SD) | 12.2 (8.1) | |
| Time of diagnosis | ||
| Last week | 0 (0) | |
| Last month | 0 (0) | |
| More than a month | 1 (0.8) | |
| Last trimester | 2 (1.5) | |
| More than six months | 9 (6.9) | |
| Within last year | 4 (3.1) | |
| More than a year | 114 (87.7) | |
| Type of treatment | ||
| Regularly | 117 (90.0) | |
| Depending on the course of the disease | 13 (10.0) | |
| Physically active | 54 (41,5) | |
| Therapist session | ||
| No | 58 (44.6) | |
| Yes in the past | 49 (37.7) | |
| Yes in the present | 23 (17.7) | |
| Other regular treatments in the past | 50 (38.5) | |
| Other regular treatments in the present | 73 (56.2) | |
| Other regular treatments in the past and/or in the present | 78 (60.0) | |
| If yes, what type | ||
| Antidepressants | 28 (38.4) | |
| Anti-anxiety | 13 (17.8) | |
| Other | 32 (43.8) | |
| Minimum | Maximum | Mean (SD) | Median (IQR) | |
| Primary sexual dysfunction subscale | 5.00 | 25.00 | 11.82 (5.26) | 11 (8 ─ 14) |
| Secondary sexual dysfunction subscale | 9.00 | 42.00 | 16.97 (6.97) | 15 (12 ─ 21) |
| Tertiary sexual dysfunction subscale | 5.00 | 25.00 | 10.85 (5.38) | 9 (7 ─ 14) |
| Fatigue severity scale | 9.00 | 63.00 | 44.92 (11.39) | 45 (40 ─ 53) |
| Desire | 1.20 | 6.00 | 3.47 (1.49) | 3.6 (2.4 ─ 4.8) |
| Arousal | 0.00 | 6.00 | 3.39 (1.97) | 3.6 (1.8 ─ 5.1) |
| Lubrication | 0.00 | 5.10 | 3.39 (1.7) | 4.2 (3 ─ 4.8) |
| Orgasm | 0.00 | 6.00 | 3.45 (2.05) | 3.6 (1.6 ─ 5.2) |
| Satisfaction | .80 | 6.00 | 3.24 (1.49) | 3.6 (2 ─ 4.4) |
| Pain | 0.00 | 6.00 | 3.87 (2.28) | 4.8 (2 ─ 6) |
| Total FSFI score | 2.00 | 32.60 | 20.8 (9.36) | 23.05 (16.9 ─ 28.5) |
| Primary sexual dysfunction subscale | Secondary sexual dysfunction subscale | Tertiary sexual dysfunction subscale | Fatigue severity scale | ||
| Desire | r | -.40 | -.16 | -.10 | -.16 |
| P | <.001 | .062 | .243 | .077 | |
| Arousal | r | -.56 | -.33 | -.21 | -.27 |
| P | <.001 | <.001 | .016 | .002 | |
| Lubrication | r | -.43 | -.30 | -.14 | -.19 |
| P | <.001 | .001 | .109 | .028 | |
| Orgasm | r | -.56 | -.39 | -.28 | -.29 |
| P | <.001 | <.001 | .001 | .001 | |
| Satisfaction | r | -.38 | -.25 | -.12 | -.20 |
| P | <.001 | .004 | .177 | .020 | |
| Pain | r | -.31 | -.25 | -.18 | -.09 |
| P | <.001 | .004 | .046 | .317 | |
| Total FSFI score | r | -.59 | -.36 | -.24 | -.23 |
| P | <.001 | <.001 | .005 | .008 | |
| Fatigue severity scale | |||
| β (SE)+ | P | ||
| Age | 50+ (reference) | ||
| 18-34 | 0.003 (0.061) | .958 | |
| 35-50 | 0.005 (0.048) | .916 | |
| Married/ Living together | No (reference) | ||
| Yes | 0.027 (0.033) | .407 | |
| Educational level | MSc/ PhD (reference) | ||
| High school at most | 0.042 (0.031) | .175 | |
| University | 0.081 (0.033) | .016 | |
| Children | No (reference) | ||
| Yes | -0.016 (0.035) | .651 | |
| Menopause | No (reference) | ||
| Yes | 0.055 (0.040) | .167 | |
| Time of diagnosis | Within one year (reference) | ||
| More than a year | 0.108 (0.039) | .035 | |
| Type of treatment | Regularly (reference) | ||
| Depending on the course of the disease | -0.061 (0.047) | .195 | |
| Therapist session | No (reference) | ||
| Yes | 0.022 (0.026) | .401 | |
| Other regular treatment in the past/in the present | No (reference) | ||
| Yes | 0.050 (0.025) | .041 | |
| Primary sexual dysfunction subscale | Secondary sexual dysfunction subscale | Tertiary sexual dysfunction subscale | |||||
| β (SE)+ | P | β (SE)+ | P | β (SE)+ | P | ||
| Age | 50+ (reference) | ||||||
| 18-34 | 0.056 (0.079) | .477 | -0.045 (0.063) | .473 | 0.070 (0.084) | .410 | |
| 35-50 | 0.060 (0.063) | .337 | -0.055 (0.049) | .273 | 0.054 (0.067) | .416 | |
| Married/ Living together | No (reference) | ||||||
| Yes | -0.003 (0.042) | .936 | -0.065 (0.033) | .050 | -0.115 (0.045) | .012 | |
| Educational level | MSc/ PhD (reference) | ||||||
| High school at most | -0.034 (0.040) | .397 | 0.027 (0.032) | .406 | -0.003 (0.043) | .940 | |
| University | -0.047 (0.044) | .289 | -0.032 (0.035) | .367 | 0.004 (0.047) | .940 | |
| Children | No (reference) | ||||||
| Yes | 0.079 (0.035) | .045 | 0.013 (0.036) | .719 | 0.040 (0.048) | .403 | |
| Menopause | No (reference) | ||||||
| Yes | 0.02 (0.052) | .699 | -0.032 (0.041) | .438 | 0.048 (0.055) | .386 | |
| Time of diagnosis | Within one year (reference) | ||||||
| More than a year | 0.106 (0.052) | .035 | 0.056 (0.044) | .202 | 0.061 (0.059) | .299 | |
| Type of treatment | Regularly (reference) | ||||||
| Depending on the course of the disease | 0.116 (0.061) | .057 | -0.004 (0.048) | .939 | 0.017 (0.064) | .793 | |
| Therapist session | No (reference) | ||||||
| Yes | 0.009 (0.034) | .792 | 0.026 (0.027) | .338 | 0.042 (0.036) | .246 | |
| Other regular treatments in the past/in the present | No (reference) | ||||||
| Yes | 0.042 (0.036) | .252 | -0.013 (0.029) | .652 | -0.004 (0.038) | .924 | |
| Fatigue severity scale | 0,005 (0,002) | .002 | 0.007 (0.001) | <.001 | 0.005 (0.002) | .003 | |
| Desire | Arousal | Lubrication | Orgasm | Satisfaction | Pain | Total FSFI score | |||||||||
| β (SE)+ | P | β (SE)+ | P | β (SE)+ | P | β (SE)+ | P | β (SE)+ | P | β (SE)+ | P | β (SE)+ | P | ||
| Age | 50+ (reference) | ||||||||||||||
| 18-34 | 0.056 (0.089) | .534 | 0.098 (0.108) | .363 | 0.105 (0.108) | .332 | 0.03 (0.112) | .792 | -0.041 (0.117) | .728 | -0.068 (0.129) | .598 | 0.074 (0.142) | .604 | |
| 35-50 | 0.047 (0.072) | .509 | 0.131 (0.086) | .134 | 0.127 (0.087) | .144 | 0.103 (0.090) | .254 | 0.014 (0.094) | .883 | -0.059 (0.104) | .572 | 0.111 (0.114) | .333 | |
| Married/ Living together | No (reference) | ||||||||||||||
| Yes | -0.015 (0.049) | .750 | 0.074 (0.059) | .210 | 0.055 (0.059) | .346 | 0.054 (0.061) | .375 | 0.14 (0.064) | .030 | 0.095 (0.07) | .179 | 0.079 (0.077) | .304 | |
| Educational level | MSc/ PhD (reference) | ||||||||||||||
| High school at most | 0.066 (0.045) | .146 | -0.014 (0.055) | .801 | -0.025 (0.055) | .648 | -0.017 (0.057) | .771 | -0.012 (0.06) | .842 | 0.002 (0.066) | .975 | 0.004 (0.072) | .951 | |
| University | 0.017 (0.049) | .724 | -0.011 (0.059) | .853 | -0.010 (0.059) | .865 | -0.032 (0.061) | .607 | 0.018 (0.064) | .784 | 0.025 (0.071) | .728 | 0.008 (0.078) | .920 | |
| Children | No (reference) | ||||||||||||||
| Yes | -0.006 (0.05) | .900 | -0.134 (0.061) | .047 | -0.003 (0.061) | .955 | -0.028 (0.063) | .659 | -0.034 (0.066) | .607 | -0.006 (0.073) | .933 | -0.021 (0.08) | .792 | |
| Menopause | No (reference) | ||||||||||||||
| Yes | -0.101 (0.048) | .046 | -0.091 (0.07) | .195 | -0.141 (0.070) | .047 | -0.158 (0.073) | .032 | -0.181 (0.076) | .019 | -0.327 (0.084) | <.001 | -0.219 (0.092) | .019 | |
| Time of diagnosis | Within one year (reference) | ||||||||||||||
| More than a year | -0.15 (0.059) | .012 | -0.16 (0.073) | .039 | -0.014 (0.074) | .855 | -0.028 (0.076) | .710 | -0.151 (0.074) | .040 | 0.045 (0.088) | .610 | -0.191 (0.090) | .029 | |
| Type of treatment | Regularly (reference) | ||||||||||||||
| Depending on the course of the disease | -0.050 (0.068) | .460 | -0.038 (0.082) | .641 | -0.19 (0.078) | .017 | -0.080 (0.085) | .347 | -0.22(0.84) | .010 | -0.052 (0.099) | .596 | -0.18 (0.100) | .082 | |
| Therapist session | No (reference) | ||||||||||||||
| Yes | -0.017 (0.038) | .643 | -0.036 (0.045) | .424 | -0.013 (0.046) | .773 | -0.057 (0.047) | .227 | -0.078 (0.049) | .118 | -0.009 (0.054) | .864 | -0.032 (0.06) | .594 | |
| Other regular treatments in the past/in the present | No (reference) | ||||||||||||||
| Yes | 0.002 (0.04) | .956 | -0.055 (0.048) | .256 | -0.027 (0.048) | .573 | -0.029 (0.050) | .566 | -0.003 (0.053) | .957 | -0.016 (0.058) | .785 | -0.026 (0.064) | .685 | |
| Primary sexual dysfunction subscale | -0,019 (0,005) | <.001 | -0.019 (0.006) | .002 | -0.009 (0.006) | .136 | -0.016 (0.006) | .009 | -0.011 (0.006) | .046 | -0.004 (0.007) | .532 | -0.016 (0.008) | .035 | |
| Secondary sexual dysfunction subscale | -0,001 (0,005) | .878 | 0.000 (0.006) | .957 | -0.005 (0.006) | .341 | -0.004 (0.006) | .474 | -0.008 (0.006) | .208 | -0.012 (0.007) | .065 | -0.008 (0.007) | .269 | |
| Tertiary sexual dysfunction subscale | -0,010 (0,005) | .047 | -0.007 (0.006) | .245 | -0.007 (0.006) | .248 | -0.007 (0.007) | .302 | -0.013 (0.007) | .044 | -0.007 (0.008) | .369 | -0.014 (0.008) | .098 | |
| Fatigue severity scale | 0.000 (0,002) | .816 | -0.002 (0.002) | .315 | -0.003 (0.002) | .248 | -0.003 (0.002) | .207 | -0.001 (0.002) | .597 | 0.001 (0.003) | .773 | -0.002 (0.003) | .424 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).